Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis

For patients with acute myeloid leukemia (AML) in complete remission without an acceptable HLA donor, the autologous hematopoietic stem cell transplantation (AHSCT) may remain a therapeutic option as remission consolidation, however its role is still a subject of continued debate. One hundred and tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Helbig, Grzegorz, Koclęga, Anna, Woźniczka, Krzysztof, Kopera, Małgorzata, Kyrcz-Krzemień, Sławomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972158/
https://www.ncbi.nlm.nih.gov/pubmed/28660547
http://dx.doi.org/10.1007/s12253-017-0266-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972158/
https://www.ncbi.nlm.nih.gov/pubmed/28660547
http://dx.doi.org/10.1007/s12253-017-0266-7

Ejemplares similares